Skip to main content
. 2023 Aug 8;21(8):e3002214. doi: 10.1371/journal.pbio.3002214

Table 2. Cumulative virus load, mutant load, IRF, and ERF of mutagenic treatment.

Value of a1 Cumulative mutant viral load with no treatment Y00 (×1,000) Cumulative mutant viral load with treatment Y01 (×1,000) Evolutionary risk factor Y01/Y00 Cumulative viral load with no treatment V00 (×109) Cumulative viral load with treatment V01 (×109) Infectivity risk factor V01/V00
Treatment starts at peak virus load
7.69 1,488 758 0.51 21.9 10.3 0.47
7.76 1,030 634 0.62 17.0 9.2 0.54
7.92 596 458 0.77 11.5 7.5 0.65
8.07 428 363 0.85 8.9 6.4 0.72
8.76 197 191 0.97 4.8 4.1 0.86
Treatment starts at infection
7.69 1,488 343 0.23 21.9 2.4 0.11
7.76 1,030 297 0.29 17.0 2.1 0.13
7.92 596 228 0.38 11.5 1.7 0.15
8.07 428 189 0.44 8.9 1.5 0.17
8.76 197 112 0.57 4.8 1.0 0.20

We show numerical results for individuals that differ in their immune competence, which affects the clearance rate, a1, during adaptive immunity. Patients that are less immunocompetent benefit more from mutagenic treatment (lower IRF) and also have a lower ERF. Parameters: a0 = 3 per day, b = 7.61 per day, u0 = 10−6 per bp, u1 = 3∙10−6 per bp, m = 20,000, n = 1, T = 5 days. Initial condition: x0 = 1 and y0 = 0.

ERF, evolutionary risk factor; IRF, infectiousness risk factor.